
A new meta-analysis connects ADHD with higher mortality risk. According to senior author Joshua Stott, the key finding is that many of the risk factors can be modified.

Helping managed care executives succeed every day.

A new meta-analysis connects ADHD with higher mortality risk. According to senior author Joshua Stott, the key finding is that many of the risk factors can be modified.

CGM users with type 2 diabetes not on insulin lowered A1C by 1.6 points over 26 weeks, 0.9 points more than finger-stick users, in the Dexcom-sponsored CONNECT study. Dexcom’s Jessica Castle, M.D., explains. hubs.ly/Q04Dn2HD0

Dr. Reddy’s twice-yearly generic lenacapavir for HIV prevention receives FDA tentative approval, with supplies expected in 120 countries by end of 2026. hubs.li/Q04D2MDl0

Two minutes. One argument. No interruptions. Meet 𝐌𝐲 𝐓𝐰𝐨 𝐂𝐞𝐧𝐭𝐬, our new series. First up: Christine Johnston of Foundational Pharmacy Strategies on how Payers pick PBMs. Watch: hubs.li/Q04CWq4l0 #ManagedCare #PBM

inMIND and EPCORE FL-1 both showed PFS gains when tafasitamab or epcoritamab was added to rituximab plus lenalidomide. Christina Poh, M.D., explains what that means for relapsed or refractory #FollicularLymphoma. Full Episode: hubs.li/Q04BDD4j0 #Lymphoma #Oncology

46% of patients with type 2 diabetes not on insulin reached A1C <7.0% with a continuous glucose monitor, vs. 24% in the control group, per a new NEJM study.

Join us for a postelection discussion examining what the 2026 midterm elections mean for healthcare policy and managed care leaders. 💻 Free webinar on Thursday, Nov. 5, at 12 p.m. EST 👉 Register now: hubs.li/Q04BCBXv0 #HealthcarePolicy #ManagedCare #340BReform

Vision is part of burn recovery, according to Abdullah Ahmed, a research fellow at the University of Illinois Chicago Department of Ophthalmology and Visual Sciences. Questioning patients about trouble seeing during follow-up could help identify people who need support, he said.

Up to 20% of glaucoma patients face severe vision loss even while in treatment for decades, but new virtual reality perimetry at-home testing may be able to change that, according to Jonathan Myers, M.D., the chief of glaucoma service at Wills Eye Hospital.

Get excited, HSES 2026 starts TOMORROW!🌉 The countdown is nearly over, and we can’t wait to see you there! Register now: hubs.li/Q04x3Tqs0

Time to start packing! We’re just 2 days away from the 2026 Health System Executive Summit in San Francisco! We can’t wait to welcome you! Register now: hubs.li/Q04x3T120

Just 3 days until the conversations begin. 𝟐𝟎+ 𝐒𝐩𝐞𝐚𝐤𝐞𝐫𝐬 from Providence, Sutter, UC Davis, UCSF, City of Hope and MORE! 📅 𝐎𝐜𝐭𝐨𝐛𝐞𝐫 𝟏𝟔 | 𝐒𝐚𝐧 𝐅𝐫𝐚𝐧𝐜𝐢𝐬𝐜𝐨 Register for FREE: hubs.ly/Q04zY2Gx0 #HSES2026 #sanfrancisco #healthcareevent #managedcare

McKesson and private equity firm CD&R will acquire Option Care Health, the largest independent home infusion company in the U.S., in a $5.8 billion deal. hubs.li/Q04zwPVj0

"The science has really outpaced our ability as a care delivery system to keep up with it." Dan Nardi of Reimagine Care on AI triage and connected devices in outpatient cancer care. hubs.li/Q04zdmNK0

Healthcare leaders are often tasked with making difficult decisions while balancing patient outcomes, organizational priorities, regulatory requirements, and financial realities. Join us for this keynote session!

New mouse data point to salt as a driver of lean MASH hubs.li/Q04z4Ltj0